Adverse Effects of Antiretroviral Therapy
Lancet 356:1423-1430, Carr,A. &Cooper, D.A., 2000
Clinicopathologic Conference, HIV Type 2 Infection & Cerebral Toxoplasmosis
NEJM 383:859-866, Case 27-2020, 2020
Varicella-Zoster Virus Infections in Patients Treated with Fingolimod
JAMA Neurol 72:31-39,10, Arvin, A.M.,et al, 2015
Prevalence and Distribution of VZV in Temporal Arteries of Patients with Giant Cell
Neurol 84:1948-1955, Gilden, D.,et al, 2015
Clinicopathologic conference, Neurologic form of immune reconstitution inflammatory syndrome (neuro-IRIS), without evidence of concurrent opportunistic infection
NEJM 362:2343-2352, Case 18-2011, 2011
Impact of Late Diagnosis and Treatment on Life Expectancy in People with HIV-1: UK Collaborative HIV Cohort (UK CHIC) Study
BMJ 343:d6016,d6015, May, M.,et al, 2011
Clinicopath Conf, Acute HIV-1 Infection
NEJM 360:1540-1548, Case 11-2009, 2009
Changes in the Incidence and Predictors of Human Immunodeficiency Virus-Associated Dementia in the Era of Highly Active Antiretroviral Therapy
Ann Neurol 63:213-221, Bhaskaran,K.,et al, 2008
Recurrent Meningitis of Unknown Aetiology
Lancet 363:1772, Ellerin,T.B.,et al, 2004
Clinicopath Conf
Subacute Sclerosing Panencephalitis, Case 15-1998, NEJM 338:1448-1456998., , 1998
HIV-1 Protease Inhibitors
JAMA 227:145-149, Deeks,S.J.,et al, 1997
Risk Factors for Postherpetic Neuralgia
Arch Int Med 157:1217-1224, 11661997., Choo,P.W.,et al, 1997
Cytomegalovirus Encephalitis
Ann Int Med 125:577-578, Arribas,J.R.,et al, 1996
Therapy for Human Immunodeficiency Virus Infection
NEJM 328:1686-1695, Hirsch,M.S.&D'Aquila,R., 1993